University of miami division of clinical pharmacology therapeutic rounds: Ischemic renal disease

Richard A. Preston, Murray Epstein

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Ischemic renal disease (IRD) is defined as a significant reduction in glomerular filtration rate and/or loss of renal parenchyma caused by hemodynamically significant renal artery stenosis. IRD is a common and often overlooked clinical entity that presents in the setting of extrarenal arteriosclerotic vascular disease in older individuals with azotemia. IRD is an important cause of chronic renal failure and end-stage renal disease (ESRD), and many patients with a presumed diagnosis of hypertensive nephrosclerosis may actually have undiagnosed ischemic nephropathy as the cause of their ESRD. The primary reason for establishing the diagnosis of IRD is the hope that correction of a renal artery stenosis will lead to improvement of renal function or a delay in progression to ESRD. There are six typical clinical settings in which the clinician could suspect IRD: acute renal failure caused by the treatment of hypertension, especially with angiotensin-converting enzyme inhibitors; progressive azotemia in a patient with known renovascular hypertension; acute pulmonary edema superimposed on poorly controlled hypertension and renal failure; progressive azotemia in an elderly patient with refractory or severe hypertension; progressive azotemia in an elderly patient with evidence of atherosclerotic disease; and unexplained progressive azotemia in an elderly patient. It is important for the clinician to identify IRD, because IRD represents a potentially reversible cause of chronic renal failure in a hypertensive patient.

Original languageEnglish (US)
Pages (from-to)203-210
Number of pages8
JournalAmerican journal of therapeutics
Volume5
Issue number3
DOIs
StatePublished - May 1 1998

    Fingerprint

Keywords

  • Arteriosclerosis
  • End-stage renal disease
  • Hypertension
  • Ischemic renal disease
  • Renovascular hypertension

ASJC Scopus subject areas

  • Pharmacology

Cite this